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tIs Ventilation Efficiency an
Additional Target of Exercise
Training Benefits in Heart
Failure With Preserved Ejection
Fraction?
We read with interest the remarkable results by Edelmann et al. (1)
on the case series of patients with heart failure (HF) with preserved
ejection fraction (HFpEF) undergoing a program of exercise
training (ET). The researchers should be congratulated for pro-
viding this unique demonstration of the benefits of a regular
physical activity program in this setting.
Our interest primarily focuses on the improvement in symptom-
limited exercise capacity assessed by gas exchange analysis, and we
would like to ask for some informative notes about how and
whether regular exercise may have prompted any potential im-
provement in the ventilatory response to maximal exercise. As
stressed in the accompanying editorial, peak oxygen consumption
(VO2) is objective and provides a reliable level of overall exercise
erformance; however, the amount of information derived by
ardiopulmonary testing is actually much broader (2). Specifically,
n abnormal ventilatory efficiency (i.e., an increased slope of
entilation [VE] vs. CO2 production rate [VCO2]) rather than peak
O2 has been identified as a peculiar feature of an abnormal
hysiology behind exercise limitation in HFpEF (3,4), and the degree
f ventilation efficiency in diastolic HF is actually prognostic (5).
here is some evidence on how ventilation efficiency may be positively
odulated by ET programs in patients with systolic HF (6).
The researchers reported that maximal ventilatory exchange, al-
hough increased, did not significantly change after ET, but it would
e helpful to know whether the VE versus VCO2 slope was actually
mproved. Indeed, an improved VE versus VCO2 slope, in the
presence of no major changes in maximal ventilatory exchange, would
suggest, for similar levels of increasing exercise load, a better matching
between exercise catabolic products (CO2) and their elimination.
A potential improvement in the pattern of ventilation efficiency
ight relate to the observed changes in left ventricular diastolic
unction, providing further progress on the level of evidence of
enefits by ET interventions in HFpEF syndrome.
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Reply
In response to the comment by Drs. Guazzi and Vitelli
regarding our paper (1), we provide further details of the
multicenter Ex-DHF (Exercise Training in Diastolic Heart
Failure) pilot study investigating exercise training in heart
failure with preserved ejection fraction (HFpEF). We agree
with Drs. Guazzi and Vitelli that cardiopulmonary testing even
in a trial that is investigating exercise training allows collecting
more information than changes in peak oxygen consumption
(VO2). Drs. Guazzi and Vitelli demonstrated that beyond
educed peak VO2, disturbed ventilatory efficiency measured as
ncreased ventilation (VE)/carbon dioxide output (VCO2) slope
is of prognostic relevance also in patients with HFpEF (2).
However, the extent of the decrease in ventilatory efficiency in
HFpEF seems to also depend on disease severity (2). Despite
the relevant decreased peak VO2 in our HFpEF cohort, the mean
aseline VE/VCO2 slope values (27.2  2.9) were better than those
eported by others (2–4). Of note, the values measured in our
ilot trial suggested overall preserved ventilatory efficiency
espite our patients fulfilling the strict criteria of the European
ociety of Cardiology guidelines for the diagnosis of HFpEF
1). After 3 months of follow-up, no significant changes in
ither group or changes between the 2 groups were observed
training group 27.6 vs. 27.6, p  0.98; control group 26.3 vs.
7.0, p  0.17; the difference between groups was adjusted for
aseline values: 0.5, 2.4 to 1.5, p  0.63). Similar results
have been obtained also by others (3,4). Interestingly, like
Kitzman et al. (4), we observed increased values of VCO2 after
xercise training (training group 1.78 vs. 1.90 l/min, p  0.06;
ontrol group 1.82 vs. 1.68 l/min, p  0.13; the difference
etween groups was adjusted for baseline values: 0.26, 0.04
o 0.48, p  0.02), and we found that this increase was
ignificantly correlated with a decrease in E/e’ (r0.29, p 0.03).
RR
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May 1, 2012:1658–61This also suggests that peripheral components such as muscle
function had a share in the improvement seen in the interven-
tion group (5). After all, it is not yet clear whether exercise
training can induce an improvement in ventilatory efficiency in
HFpEF. A larger, prospective, randomized controlled trial that
is now underway (6) will contribute to clarification of this issue.
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Prevalence of J-Point Elevation
in Families With Sudden
Arrhythmic Death Syndrome
We congratulate Nunn et al. (1) for their interesting report
published recently in the Journal. They reported that J-point
elevation in the inferolateral leads was more prevalent in the
first-degree relatives of patients with sudden arrhythmic death
syndrome (SADS) than in controls. They suggested that early
repolarization was a potentially heritable proarrhythmic marker,
risk modifier for lethal arrhythmia, or marker of proarrhythmiain SADS (1). Because J-point elevation is highly prevalent in
the healthy population, the report by Nunn et al. (1) encourages
the development of better clinical algorithms. Because this
study was confined to the relatives of patients with SADS, the
significance of J-point elevation found in clinically healthy
individuals (electrocardiogram obtained for pre-operative clear-
ance, sports suitability, or job-related check) in the absence of a
family history of SADS would probably be minimal. Should it
be important to obtain family history in individuals showing
J-point elevation? The researchers highlighted that a gene
association study or linkage analysis to identify genetic candi-
dates is a logical next step. Although waiting for the availability
of more extensive knowledge on the genetic basis of J-point
elevation, the risk of missing a potential warning marker would
continue to loom in clinical practice.
The group of J-wave syndromes is a spectrum of disorders that
involve accentuation of the epicardial action potential notch in
different regions of the heart that may predispose patients to
develop phase 2 reentry and ventricular tachyarrhythmias. J-point
elevation has been divided into 3 subtypes (2,3). An early repolar-
ization pattern in the lateral precordial leads is rarely seen in
survivors of ventricular fibrillation (VF) (type 1). On the other
hand, J-point changes in inferior or inferolateral leads are usually
associated with many cases of idiopathic VF (type 2), and global
early repolarization patterns are associated with the highest risk
for development of malignant arrhythmias, including VF storms
(type 3).
We have observed J-point elevations in young carriers of
mutations of various genes (including lamin A/C and plakophilin
2), as well as in healthy relatives of patients with mutation (Fig. 1).
After the publication of Nunn et al. (1), this finding cannot be
ignored, and it will be important to develop a consensus for the
approach to healthy individuals with J-point elevation with and
without a family history of SADS.
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